Electromed Market Capitalization from 2010 to 2024
| ELMD Stock | USD 31.06 0.57 1.87% |
Check Electromed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Electromed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 684.7 K, Interest Expense of 85.2 K or Selling General Administrative of 18.5 M, as well as many indicators such as Price To Sales Ratio of 1.38, Dividend Yield of 0.0 or PTB Ratio of 2.65. Electromed financial statements analysis is a perfect complement when working with Electromed Valuation or Volatility modules.
Electromed | Market Capitalization |
Latest Electromed's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Electromed over the last few years. It is Electromed's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Electromed's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 262.71 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Electromed Market Capitalization Regression Statistics
| Arithmetic Mean | 59,162,072 | |
| Geometric Mean | 42,492,644 | |
| Coefficient Of Variation | 74.89 | |
| Mean Deviation | 38,899,293 | |
| Median | 44,483,918 | |
| Standard Deviation | 44,307,864 | |
| Sample Variance | 1963.2T | |
| Range | 118.7M | |
| R-Value | 0.90 | |
| Mean Square Error | 418.5T | |
| R-Squared | 0.80 | |
| Slope | 8,873,056 | |
| Total Sum of Squares | 27484.6T |
Electromed Market Capitalization History
About Electromed Financial Statements
Electromed stakeholders use historical fundamental indicators, such as Electromed's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Electromed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Electromed's assets and liabilities are reflected in the revenues and expenses on Electromed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Electromed. Please read more on our technical analysis and fundamental analysis pages.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of various ages in the United States and internationally. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota. Electromed operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 156 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports:Check out the analysis of Electromed Correlation against competitors. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.809 | Earnings Share 0.72 | Revenue Per Share 6.39 | Quarterly Revenue Growth 0.09 | Return On Assets 0.0839 |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.